Prognia
Drug Database
🇺🇸US · FDA ApprovedDiscontinuedANDA040793-001

A-METHAPRED(METHYLPREDNISOLONE SODIUM SUCCINATE)

Corticosteroids, weak (group I); Corticosteroids, combinations for treatment of acne; Glucocorticoids

Manufacturer: HOSPIRA INC

FDA Approval: 25/11/2008

Route: INJECTION · INJECTABLE

Active Ingredients

METHYLPREDNISOLONE SODIUM SUCCINATE EQ 40MG BASE/VIAL

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about A-METHAPRED — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.